Tuan Tran, DO
Pain Medicine · Rochester, NYNPI 1639197940
Payments from drug & device makers
Across 44 payments — averaging $114.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertos Medical, Inc.$2K
- Bioventus LLC$1K
- Nevro Corp.$388
- Abbott$300
- Medtronic$284
- Boston Scientific$254
- plus $264 from 5 others
What the payments were for
- Travel & lodging$3,26465%
- Food & beverage$1,76135%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertos Medical, Inc. | 6 | $2,064 |
| Bioventus LLC | 5 | $1,470 |
| Nevro Corp. | 12 | $388 |
| Abbott | 6 | $300 |
| Medtronic(2 entities) | 4 | $284 |
| Boston Scientific | 4 | $254 |
| Nalu Medical, Inc. | 1 | $141 |
| SPR Therapeutics, Inc | 2 | $66 |
| Saluda Medical Americas, Inc. | 2 | $26 |
| AstraZeneca | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$1,947
- Stimrouter Implantable Kit$1,438
- PROCLAIM$165
- Senza$144
- Nalu Neurostimulation System$141
- INTELLIS ADAPTIVESTIM$140
- GENERAL PAIN MANAGEMENT$139
- Omnia$103
How this compares
$5,025 in reported general payments places this provider in the 70th percentile of 503 pain medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 82 | $1,761 |
| Gabapentin | 136 | $1,609 |
| Duloxetine Hcl | 24 | $1,033 |
| Celecoxib | 55 | $746 |
| Etodolac | 11 | $667 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $624 |
| Methylprednisolone | 52 | $427 |
| Tizanidine Hcl | 31 | $316 |
| Nortriptyline Hcl | 19 | $182 |
| Cyclobenzaprine Hcl | 18 | $178 |
| Nabumetone | 14 | $175 |
| Baclofen | 12 | $173 |
| Diclofenac Sodium | 15 | $150 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $141 |
| Tramadol Hcl | 13 | $39 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Rochester
- John MarkmanRochester$300K
- Armando VillarrealRochester$34K
- Simer Preet SinghRochester$31K
- Gary SchwartzBrooklyn$756K
- Amitabh GulatiNew York$627K
- William CaldwellStony Brook$550K
- Brian DurkinPort Jefferson$459K
- Grace FordeNew Hyde Park$398K
- David SpinnerNew York$391K
- Naum ShaparinBronx$178K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.